You are viewing a single comment's thread.

view the rest of the comments →

MercurysBall2 ago

Affiliated with HHI http://hhi.harvard.edu/people/jarrod-goentzel-0

Jarrod Goentzel

Jarrod Goentzel is founder and director of the MIT Humanitarian Supply Chain Lab in the MIT Center for Transportation & Logistics.

A recent tweet of his: https://twitter.com/goentzel/status/1019493340511965184

JIT vaccines? Nathalie Imbault outlines an aggressive effort by @CEPIvaccines to develop a rapid vaccine deployment platform for emerging pathogens. #HHL2018

CEPI Vaccines = Coalition for Epidemic Preparedness Innovations https://en.wikipedia.org/wiki/Coalition_for_Epidemic_Preparedness_Innovations

The Coalition for Epidemic Preparedness Innovations (CEPI or Cepi) is a foundation that takes donations from public, private, philanthropic, and civil society organisations, which it invests in independent research projects develop vaccines against emerging infectious disease (EID).[2][3] CEPI is focused on the World Health Organisation's "blueprint priority pathogens", which includes: MERS-CoV (and latterly COVID-19), Nipah virus, Lassa fever virus, and Rift Valley fever virus, as well as Chikungunya virus.[4][3] CEPI investment also requires "equitable access" to the vaccines during outbreaks.[5]

CEPI was conceived in 2015 and formally launched in 2017 at the World Economic Forum in Davos. It was co-founded and co-funded with USD 460 million from the Bill and Melinda Gates Foundation, the The Wellcome Trust, and a consortium of sovereign nations being mainly Norway, Japan, and Germany, and more latterly the European Union (in 2019).[1][3] CEPI is headquartered in Oslo, Norway.[1][2][3] At the 2017 launch, Nature said, "It is by far the largest vaccine development initiative ever against viruses that are potential epidemic threats"

MercurysBall2 ago

Jarrod was a chair at this Georgia Tech sponsored conference in 2013: HHL Conference draws participants worldwide to address SCM in humanitarian response

In light of disastrous forest fires in the American West and ongoing humanitarian crises in war-torn Syria, the importance of timely, efficient aid and humanitarian response to disaster demands our attention. Global health and humanitarian response professionals around the world must continue to actively collaborate in search of the most innovative and effective ways to guarantee the arrival of aid to those in need, and cross-sector conferences provide a way to share information and strategize collectively...

The conference was co- organized for the 5thyear by the Georgia Tech Center for Health & Humanitarian Logistics (HHL) and the MIT Humanitarian Response Lab, and it was hosted for the first time by the Malaysia Institute for Supply Chain Innovation (MISI), a member of the MIT Global SCALE Network. The conference was made possible for the 5th year by generous support from The UPS Foundation.

..This year’s Conference brought together 113 participants from 25 countries and from NGOs such as Aidmatrix and Atlanta-based CARE to MERCY Malaysia, Nigeria-based SHI–Logistics, and the United Nations Africa Mission in Darfur (UNAMID). Industry leaders from logistics and transportation companies to global health consultants and pharmaceuticals attended the event as well as government officials, graduate students and professors from universities across the globe, and leaders from various other humanitarian-related organizations...

The Georgia Tech Center for Health & Humanitarian Logistics (HHL), a unit of the Stewart School of Industrial & Systems Engineering, is an initiative to improve humanitarian logistics (including short or long-term, man-made or natural disasters, global and public health, and long-term development needs) and ultimately the human condition by system transformations through education, outreach, projects and research. To find out more about the 2013 HHL Conference, Professional Education courses in health and humanitarian logistics, and the HHL Center at Georgia Tech, please visit: http://humanitarian.scl.gatech.edu/home.

Really, invisible ink in vaccines SMH

The technology embeds immunization records into a child’s skin

Keeping track of vaccinations remains a major challenge in the developing world, and even in many developed countries, paperwork gets lost, and parents forget whether their child is up to date. Now a group of Massachusetts Institute of Technology researchers has developed a novel way to address this problem: embedding the record directly into the skin.

Along with the vaccine, a child would be injected with a bit of dye that is invisible to the naked eye but easily seen with a special cell-phone filter, combined with an app that shines near-infrared light onto the skin. The dye would be expected to last up to five years, according to tests on pig and rat skin and human skin in a dish.

The system—which has not yet been tested in children—would provide quick and easy access to vaccination history, avoid the risk of clerical errors, and add little to the cost or risk of the procedure, according to the study, published Wednesday in Science Translational Medicine.

“Especially in developing countries where medical records may not be as complete or as accessible, there can be value in having medical information directly associated with a person,” says Mark Prausnitz, a bioengineering professor at the Georgia Institute of Technology, who was not involved in the new study.